Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human CEBPB Antibodies:
anti-Mouse (Murine) CEBPB Antibodies:
anti-Rat (Rattus) CEBPB Antibodies:
Go to our pre-filtered search.
Human Monoclonal CEBPB Primary Antibody for FACS, ELISA - ABIN969049
Cappello, Zwergal, Kanclerski, Haas, Kandemir, Huber, Page, Brand: C/EBPbeta enhances NF-kappaB-associated signalling by reducing the level of IkappaB-alpha. in Cellular signalling 2009
Human Polyclonal CEBPB Primary Antibody for GS, IHC - ABIN4297610
Gromnicova, Romero, Male: Transcriptional control of the multi-drug transporter ABCB1 by transcription factor Sp3 in different human tissues. in PLoS ONE 2012
Human Polyclonal CEBPB Primary Antibody for ELISA, WB - ABIN4297625
Canettieri, Santaguida, Antonucci, Della Guardia, Franchi, Coni, Gulino, Centanni: CCAAT/enhancer-binding proteins are key regulators of human type two deiodinase expression in a placenta cell line. in Endocrinology 2012
We found that quercetin reduces the promoter activity of apoB (show APOB Antibodies), driven by the enforced expression of C/EBPb.
Chromatin immunoprecipitation analysis revealed that C/EBPbeta2 binds to multiple sites at the 5' promoter/regulatory region, introns, and the 3' untranslated region of the IGF-II gene.
C/EBPbeta negatively regulates PR-B (show PGR Antibodies) expression in glioblastoma cells.
High CEBPB expression is associated with recurrence in Glioma.
Study results show the role of WT1 (show WT1 Antibodies) in regulating decidualization in human endometrial stromal cells. C/EBPbeta is an upstream gene that regulates WT1 (show WT1 Antibodies) expression by binding to the novel enhancer region.
EGFR (show EGFR Antibodies) and C/EBP-beta oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-beta isoform
Studied expression of CD147 in both ALK (show ALK Antibodies)+ and ALK (show ALK Antibodies)- anaplastic large-cell lymphoma; found CD147 to be a downstream target for activation by C/EBPbeta.
Data show that in an in vitro acute lung injury model established by lipopolysaccharide induction, phosphorylation of C/EBP beta was decreased and bioinformatics analysis discovered a putative binding site of C/EBP beta in CCSP1 (show KIAA1199 Antibodies) promoter; LPS (show IRF6 Antibodies) stimulation reduced C/EBP beta phosphorylation and suppressed the transcription of CCSP1 (show KIAA1199 Antibodies).
Increased polyamine metabolism in CRC (show CALR Antibodies) could be driven by c-Myc (show MYC Antibodies) and C/EBPbeta rather than Bacteroides fragilis infection.
SBDS (show SBDS Antibodies) function is specifically required for efficient translation re-initiation into the protein isoforms C/EBPalpha (show CEBPA Antibodies)-p30 (show CENPV Antibodies) and C/EBPbeta-LIP, which is controlled by a single cis (show CISH Antibodies)-regulatory upstream open reading frame (uORF) in the 5' untranslated regions (5' UTRs) of both mRNAs.
A transcription factor complex consisting of ATF6 (show ATF6 Antibodies) (an endoplasmic reticulum-resident factor) and C/EBP-beta is required for the IFN-gamma-induced (show SAMHD1 Antibodies) expression of DAPK1 (show DAPK1 Antibodies) IFN-gamma-induced (show SAMHD1 Antibodies) proteolytic processing of ATF6 (show ATF6 Antibodies) and phosphorylation of C/EBP-beta are obligatory for the formation of this transcriptional complex
Data show that CCAAT/enhancer-binding protein beta (C/EBP beta) expression is increased in endothelial cells and retinal pigment epithelial cells infected by Toxoplasma gondii, resulting in the activation of autophagy in host cells by inhibiting mechanistic target of rapamycin (show FRAP1 Antibodies) protein (mTOR (show FRAP1 Antibodies)) pathway.
elevated LIP/LAP ratio robustly increased Ogn (show OGN Antibodies) expression and cell death under stress by modulating the mitogen-activated protein kinase (show MAPK1 Antibodies)/activator protein 1 (show JUN Antibodies) pathway (MAPK (show MAPK1 Antibodies)/AP-1 (show JUN Antibodies)).
Ptn (show PTN Antibodies) may play a vital role in the progesterone-induced decidualization pathway via C/EBPB-cyclic AMP (show TMPRSS5 Antibodies)-Hand2 (show HAND2 Antibodies) signaling.
C/EBPbeta is a critical factor for Ly6C(-) monocyte survival, at least in part through upregulation of Csf1r (show CSF1R Antibodies).
these results support that decreasing C/EBPbeta expression prevents MDSC generation and decreases immunosuppression in septic mice, providing a target for sepsis treatment.
Functional characterization of C/EBPa (show CEBPA Antibodies) and C/EBPb proteomes suggests they can regulate novel pathways.
PARP-1 (show PARP1 Antibodies) attenuates adipogenesis by PARylating C/EBPb, a pro-adipogenic transcription factor, on three residues in its regulatory domain.
Results show that C/EBPbeta and C/EBPdelta (show CEBPD Antibodies) actively regulate the promotor region of both splicing variants Ppargamma1sv and Ppargamma2 (show PPARG Antibodies) in mouse adipocytes.
These results show that C/EBPbeta directs a switch from proinflammatory to repressor myeloid cells
Both gain- and loss-of-function studies showed that an accumulation of the CCAAT/enhancer binding protein-beta (C/EBP-beta) protein, which cooperates with dominant transcriptional co-regulator PR domain containing 16 (PRDM16 (show PRDM16 Antibodies)) to determine brown/beige (show LYST Antibodies) adipocyte lineage, is essential for the enhanced adipocyte browning caused by the loss of ZIP13 (show SLC39A13 Antibodies)
monocyte differentiation occurred through de novo enhancer establishment and activation of pre-established (poised) enhancers. Generation of Ly6C(-) monocytes involved induction of the transcription factor C/EBPbeta and C/EBPbeta-deficient mice lacked Ly6C(-) monocytes.
C/EBP-beta plays a vital role in regulating GPR120 (show O3FAR1 Antibodies) transcription.
The expression of porcine Prdx6 (show PRDX6 Antibodies) gene is up-regulated by C/EBPbeta and CREB (show CREB1 Antibodies).
Results show that expression changes of IGF1 (show IGF1 Antibodies) genes were associated with C/EBP (show CEBPA Antibodies) b expression during embryonic and postnatal development in porcine liver.
FoxO1 (show FOXO1 Antibodies) and C/EBPb regulate preadipocyte adipogenesis possibly through C/EBPb-> FoxO1 (show FOXO1 Antibodies)-> C/EBPb feedback regulatory loop and FoxO1 (show FOXO1 Antibodies)-C/EBPb protein complex.
the pig GPD1 (show GPD1 Antibodies) gene is regulated negatively by C/EBP beta in cultured kidney cells
GATA-4 (show GATA4 Antibodies) and C/EBPbeta are both required for FSH (show BRD2 Antibodies) +/- IGF-I (show IGF1 Antibodies) stimulation of the porcine steroidogenic acute regulatory protein (show STAR Antibodies) gene promoter in homologous granulosa cell cultures.
The differential expression of specific CEBPA (show CEBPA Antibodies)/B isoforms observed in maturing follicles and CL may contribute to changes in follicular cell differentiation and increasing steroidogenic capacity.
SREBP1a activated while C/EBP (show CEBPA Antibodies) factors downregulated the activity of the SCD1 (show SCD Antibodies) promoter.
These results indicate that the C/EBPbeta gene plays an important regulatory role in regulation of the cell cycle regulators and spermatogenesis-related (show SYCE2 Antibodies) genes expression and function of bovine SCs (show TWIST1 Antibodies).
Suppression of CPT1B (show CPT1B Antibodies) and induction of SCD (show SCD Antibodies) and CEBPB by supplemental arginine promotes increased adiposity in Angus steers.
Co-culture of adipocytes and myoblasts elicited an increase in C/EBPbeta and PPAR-gamma (show PPARG Antibodies) gene expression in differentiated myoblasts and an increase in GPR43 (show FFAR2 Antibodies) gene expression in adipocytes.
Interaction of C/EBP-beta and NF-Y factors constrains activity levels of the nutritionally controlled promoter IA expressing the acetyl-CoA carboxylase-alpha (show ACACA Antibodies) gene in cattle.
The role of NF-kappaB (show NFKB1 Antibodies) and C/EBP (show CEBPA Antibodies) factors in regulating basal and pathogen-induced expression of both genes from cattle, is investigated.
The 3' terminal end of the first intron of porcine SPP1 (show SPP1 Antibodies) harbors a C/EBPbeta binding site and this binding site is negatively affected by the mutant G allele.
The protein encoded by this intronless gene is a bZIP transcription factor which can bind as a homodimer to certain DNA regulatory regions. It can also form heterodimers with the related proteins CEBP-alpha, CEBP-delta, and CEBP-gamma. The encoded protein is important in the regulation of genes involved in immune and inflammatory responses and has been shown to bind to the IL-1 response element in the IL-6 gene, as well as to regulatory regions of several acute-phase and cytokine genes. In addition, the encoded protein can bind the promoter and upstream element and stimulate the expression of the collagen type I gene.
CCAAT/enhancer binding protein (C/EBP), beta
, CCAAT/enhancer-binding beta protein b
, CCAAT/enhancer-binding protein beta
, CCAAT/enhancer binding protein beta
, interleukin 6-dependent DNA-binding protein
, liver-enriched transcriptional activator protein
, nuclear factor NF-IL6
, nuclear factor of interleukin 6
, transcription factor 5
, C/EBP BETA
, interleukin-6-dependent-binding protein
, liver-enriched transcriptional activator
, nuclear protein Il6
, C/EBP beta
, c/EBP-related protein 2
, liver activating protein (LAP)
, nuclear factor-IL6
, silencer factor B
, c/EBP beta
, CCAAT box/enhancer binding protein beta
, CCR protein
, transcription factor NF-M